Bone morphogenetic protein-4 contributes to the down-regulation of Kv4.3 K+ channels in pathological cardiac hypertrophy

Biochemical and Biophysical Research Communications

Volumn 436, Issue 4, 2013, Pages 591-594

  Sun, Bo ^a   Sheng, Yue ^a   Huo, Rong ^a   Hu, Chao Wei ^a   Lu, Jing ^a   Li, Shan Liang ^a   Liu, Xiao ^a   Wang, Yu Chun ^a   Dong, De Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 4; Hypertrophy; Kv4.3 K+ channel

Indexed keywords

APOCYNIN; BONE MORPHOGENETIC PROTEIN 4; MESSENGER RNA; NOGGIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.4; POTASSIUM CHANNEL KV4.3; REACTIVE OXYGEN METABOLITE; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA CONSTRICTION; ARTICLE; DOWN REGULATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

BONE MORPHOGENETIC PROTEIN-4; HYPERTROPHY; KV4.3 K(+) CHANNEL;

ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 4; CARDIOMEGALY; DNA PRIMERS; DOWN-REGULATION; HUMANS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; SHAL POTASSIUM CHANNELS;

EID: 84880039758     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.113     Document Type: Article

References (13)

1. Cheng S., Vasan R.S. Advances in the epidemiology of heart failure and left ventricular remodeling. Circulation 2011, 124:e516-519.
2. Liu H.B., Yang B.F., Dong D.L. Calcineurin and electrical remodeling in pathologic cardiac hypertrophy. Trends Cardiovasc. Med. 2010, 20:148-153.
3. Takimoto K., Li D., Hershman K.M., Li P., Jackson E.K., Levitan E.S. Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ. Res. 1997, 81:533-539.
4. Guo W., Kamiya K., Hojo M., Kodama I., Toyama J. Regulation of Kv4.2 and Kv1.4 K+ channel expression by myocardial hypertrophic factors in cultured newborn rat ventricular cells. J. Mol. Cell. Cardiol. 1998, 30:1449-1455.
5. Tozakidou M., Goltz D., Hagenstrom T., Budack M.K., Vitzthum H., Szlachta K., Bahring R., Ehmke H. Molecular and functional remodeling of I(to) by angiotensin II in the mouse left ventricle. J. Mol. Cell. Cardiol. 2010, 48:140-151.
6. Zhou C., Ziegler C., Birder L.A., Stewart A.F., Levitan E.S. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ. Res. 2006, 98:1040-1047.
7. Lebeche D., Kaprielian R., del Monte F., Tomaselli G., Gwathmey J.K., Schwartz A., Hajjar R.J. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 2004, 110:3435-3443.
8. Sun B., Huo R., Sheng Y., Li Y., Xie X., Chen C., Liu H.B., Li N., Li C.B., Guo W.T., Zhu J.X., Yang B.F., Dong D.L. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy. Hypertension 2013, 61:352-360.
9. Dixon J.E., Shi W., Wang H.S., McDonald C., Yu H., Wymore R.S., Cohen I.S., McKinnon D. Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ. Res. 1996, 79:659-668.
10. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. USA 2010, 107:15565-15570.
11. Zhang T.T., Takimoto K., Stewart A.F., Zhu C., Levitan E.S. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ. Res. 2001, 88:476-482.
12. Matsubara H., Suzuki J., Inada M. Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy. J. Clin. Invest. 1993, 92:1659-1666.
13. Bodi I., Muth J.N., Hahn H.S., Petrashevskaya N.N., Rubio M., Koch S.E., Varadi G., Schwartz A. Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: complex nature of K+ current changes and action potential duration. J. Am. Coll. Cardiol. 2003, 41:1611-1622.